SPY382.33-9.44 -2.41%
DIA313.98-5.55 -1.74%
IXIC13,119.43-478.54 -3.52%

Bolt Biotherapeutics Is a Clinical-Stage Immuno-Oncology Company

Bolt Biotherapeutics Is a Clinical-Stage Immuno-Oncology Company

· 02/04/2021 22:42

(END) Dow Jones Newswires

February 04, 2021 22:42 ET (03:42 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.